Biomarin Pharmaceutical Inc. SEC filings
In the twelve months since 9 October 2025 Biomarin Pharmaceutical Inc. filed 31 documents with the SEC of the kinds listed here: 23 current reports (8-K), about 7 results of operations; 7 other events; 7 regulation fd disclosure; 6 material agreement; 3 officer or director change; 3 quarterly reports (10-Q), 1 employee share plan registration (S-8), 1 additional proxy material (DEFA14A), 1 proxy statement (DEF 14A), 1 annual report to shareholders (ARS), 1 annual report (10-K). The latest, filed 6 October 2026: 8-K, results of operations.
| Filed | Form | What it was about | Period or event date | Filing |
|---|---|---|---|---|
| 6 October 2026 | 8-K | Results of operations | 6 October 2026 | EDGAR |
| 30 September 2026 | 8-K | Material agreement | 24 September 2026 | EDGAR |
| 15 September 2026 | 8-K | Other events | 15 September 2026 | EDGAR |
| 14 September 2026 | 8-K | Officer or director change | 10 September 2026 | EDGAR |
| 1 September 2026 | 8-K | Other events | 31 August 2026 | EDGAR |
| 31 August 2026 | 8-K | Material agreement, Regulation FD disclosure | 30 August 2026 | EDGAR |
| 18 August 2026 | 8-K | Material agreement, Regulation FD disclosure | 17 August 2026 | EDGAR |
| 6 August 2026 | S-8 | employee share plan registration | EDGAR | |
| 6 August 2026 | 10-Q | quarterly report | 30 June 2026 | EDGAR |
| 6 August 2026 | 8-K | Results of operations | 6 August 2026 | EDGAR |
| 13 July 2026 | 8-K/A | Other events | 27 April 2026 | EDGAR |
| 4 June 2026 | 8-K | Officer or director change, Shareholder vote | 2 June 2026 | EDGAR |
| 5 May 2026 | 10-Q | quarterly report | 31 March 2026 | EDGAR |
| 4 May 2026 | 8-K | Results of operations | 4 May 2026 | EDGAR |
| 27 April 2026 | 8-K | Material agreement, Acquisition or disposition completed, New financial obligation, Regulation FD disclosure | 27 April 2026 | EDGAR |
| 23 April 2026 | 8-K | Other events | 23 April 2026 | EDGAR |
| 21 April 2026 | DEFA14A | additional proxy material | EDGAR | |
| 21 April 2026 | DEF 14A | proxy statement | 2 June 2026 | EDGAR |
| 21 April 2026 | ARS | annual report to shareholders | 31 December 2025 | EDGAR |
| 16 March 2026 | 8-K | Other events | 16 March 2026 | EDGAR |
| 26 February 2026 | 10-K | annual report | 31 December 2025 | EDGAR |
| 23 February 2026 | 8-K | Results of operations | 23 February 2026 | EDGAR |
| 12 February 2026 | 8-K | Material agreement, New financial obligation, Regulation FD disclosure | 12 February 2026 | EDGAR |
| 29 January 2026 | 8-K | Regulation FD disclosure | 29 January 2026 | EDGAR |
| 26 January 2026 | 8-K | Results of operations, Regulation FD disclosure, Other events | 26 January 2026 | EDGAR |
| 12 January 2026 | 8-K | Results of operations | 12 January 2026 | EDGAR |
| 22 December 2025 | 8-K | Other events | 19 December 2025 | EDGAR |
| 19 December 2025 | 8-K | Material agreement, Regulation FD disclosure | 19 December 2025 | EDGAR |
| 17 December 2025 | 8-K | Officer or director change | 11 December 2025 | EDGAR |
| 28 October 2025 | 10-Q | quarterly report | 30 September 2025 | EDGAR |
| 27 October 2025 | 8-K | Results of operations | 27 October 2025 | EDGAR |
Read more
Form 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.Source
The company's filing index on EDGAR, read from the SEC's submissions feed.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.